AMEV-Applied Molecular Evolution Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMEV-Applied Molecular Evolution

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (76)	1/23/2003 2:33:41 PM
From: keokalani'nui	Read Replies (2) of 164

Actually, that would be the hot money from amev. I like the way they husband the cash, the JPM sponsorship, Brightmyer, numax and vitaxin; but boy I wish they would not hype pre-toxicology products. And I wish I understood why its ceo sounds so very uncomfortable telling the story; the last times I sensed similar stress in a senior executive's voice crgn started a long slide and cat's ceo quit. It may be stage fright, and very personal, which I could understand and sympathize with. But if you listen you will agree, it is unnerving. BTW, amev's lead drug and IND filing is going to be on perC6. Brightmyer said it works real good. And he has to produce enough through P2. :) Wilder

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next